Target intelligence / Profile preview

Neovascularization via Endothelial Progenitor Cell Activity

Molecular classification
Other (Biological Process)
01

Overview

Neovascularization via endothelial progenitor cell activity refers to the process by which endothelial progenitor cells (EPCs) contribute to the formation of new blood vessels. This process involves the mobilization of EPCs from the bone marrow into the circulation, their recruitment to sites of neovascularization, and their differentiation into mature endothelial cells. EPCs also release paracrine factors that support angiogenesis. This process is crucial in various physiological and pathological conditions, including wound healing, ischemic diseases, and cancer progression.

Other names
Endothelial Progenitor Cell-Mediated NeovascularizationEPC-Mediated Angiogenesis
02

Mechanism of action

Inhibition or enhancement of angiogenic factors (e.g., VEGF) Modulation of EPC mobilization and differentiation

03

Biological functions

Cell proliferationAngiogenesisVasculogenesisTissue repairWound healing
04

Disease associations

CancerCardiovascular diseaseIschemic diseasesPregnancy-related diseases
05

Safety considerations

Potential for promoting tumor growthRisk of exacerbating ischemic conditions if not properly controlled
06

Interacting drugs

bevacizumab (anti-VEGF antibody)
07

Biomarkers

Circulating endothelial progenitor cells (EPCs)VEGF levelsCD34+/CD133+ cell counts

Beyond the preview

Go deeper on Neovascularization via Endothelial Progenitor Cell Activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neovascularization via Endothelial Progenitor Cell Activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call